Agea | Colon cancer | Rectal and anal cancer | ||
---|---|---|---|---|
AAPC | 95% CI | AAPC | 95% CI | |
Men | ||||
30–34 | –b | –b | –b | –b |
35–39 | –b | –b | −3.3 | −8.5 to 2.1 |
40–44 | 2.7c | 0.3 to 5.1 | −1.2 | −4.5 to 2.3 |
45–49 | −1.2 | −3.5 to 1.2 | 0.6 | −1.0 to 2.3 |
50–54 | 2.8c | 1.4 to 4.3 | 1.5 | −0.2 to 3.2 |
55–59 | 3.1c | 2.1 to 4.1 | 2.1c | 1.2 to 3.1 |
60–64 | 3.1c | 2.1 to 4.2 | 2.0c | 1.3 to 2.7 |
65–69 | 2.5c | 1.7 to 3.3 | 1.5c | 0.7 to 2.2 |
70–74 | 2.9c | 2.0 to 3.8 | 0.7 | −0.1 to 1.4 |
75–79 | 2.9c | 1.9 to 3.8 | 1.8c | 0.6 to 3.0 |
All men | 2.6c | 2.2 to 3.0 | 1.4c | 1.1 to 1.7 |
Women | ||||
30–34 | –b | –b | –b | –b |
35–39 | 1.7 | −2.4 to 6.0 | –b | –b |
40–44 | −0.8 | −4.2 to 2.7 | −0.1 | −3.0 to 2.9 |
45–49 | −0.2 | −2.3 to 1.8 | 1.2 | −1.6 to 4.0 |
50–54 | 2.3c | 0.4 to 4.3 | 0.1 | −1.9 to 2.2 |
55–59 | 2.4c | 0.5 to 4.4 | 0.3 | −0.8 to 1.4 |
60–64 | 2.2c | 1.3 to 3.1 | −0.7 | −1.9 to 0.5 |
65–69 | 1.4c | 0.5 to 2.4 | −0.1 | −0.8 to 0.7 |
70–74 | 1.6c | 0.8 to 2.5 | 0.6 | −0.2 to 1.5 |
75–79 | 1.7c | 0.8 to 2.7 | 1.0 | −0.1 to 2.2 |
All women | 1.7c | 1.1 to 2.3 | 0.2 | −0.2 to 0.7 |